gallocatechol has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, EP; Shih, CJ; Tang, FY | 1 |
| Bazinet, L; Cao, S; Christensen, KA; Clardy, J; Cryan, LM; Habeshian, KA; Rogers, MS | 1 |
2 other study(ies) available for gallocatechol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells.
Topics: Catechin; Cell Movement; Endothelium, Vascular; Ephrin-A1; Ephrin-A2; Humans; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Recombinant Proteins; Tea; Umbilical Veins | 2007 |
1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Proliferation; Endothelial Cells; Humans; Hydrolyzable Tannins; Mice; Neovascularization, Pathologic; Receptors, Peptide | 2013 |